# Laminar

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/laminar-2

- Industry: Medical Devices & Equipment
- Headquarters: Santa Rosa, US
- Website: www.laminarlaa.com
- Total disclosed funding: $5M
- Latest round: Series A (Nov 15, 2019)
- Investors on record: 1

## About

Based in Santa Rosa, US, and founded in 2019, Laminar, Inc. is a MedTech company that engages in the development of medical devices intended for use in LAA (Left Atrial Appendage) closure procedures. As of February 2024, the company is being led by Randy Lashinski, as its President and Chief Executive Officer. In November 2023, Johnson & Johnson, Inc. acquired Laminar, Inc. from Santé Ventures for USD 400 million.

Laminar, Inc. focuses on the development of a catheter-based Left Atrial Appendage (LAA) closure device. The company's product is used by surgeons to seal off the left atrial appendage in patients with atrial fibrillation. The device prevents blood from reaching that location, lowering the risk of a thromboembolic stroke.

## Funding rounds

- Series A, Nov 15, 2019, $5M — Sante Ventures

## Investors

- Sante Ventures (https://capitalatlas.ai/funds/sante-ventures) — Series A